GeneDx Holdings Corp. Warrant
WGSWW
About: GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
Employees: 1,000
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.84% more ownership
Funds ownership: 10.1% [Q1] → 10.95% (+0.84%) [Q2]
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
7% less funds holding
Funds holding: 14 [Q1] → 13 (-1) [Q2]
63% less capital invested
Capital invested by funds: $595K [Q1] → $220K (-$375K) [Q2]
Financial journalist opinion
We haven’t received any recent news articles for WGSWW